Navigation Links
U.S. FDA Issues Action Letter for Sugammadex
Date:8/1/2008

KENILWORTH, N.J., Aug. 1 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP) today announced that the U.S. Food and Drug Administration (FDA) has issued a "not-approvable" letter for sugammadex sodium injection for the reversal of muscle relaxation during general anesthesia.

"We are surprised and disappointed with this action, especially given that sugammadex received a unanimous recommendation for approval by the FDA Advisory Committee on Anesthetics and Life Support in March of this year," said Thomas P. Koestler, Ph.D., executive vice president and president of Schering-Plough Research Institute. "Sugammadex represents the first major pharmaceutical innovation in the field of anesthesia in two decades. We remain committed to bringing this important medical advance to those who are waiting for it in the United States, and plan to work with the agency to address the issues, which are primarily related to hypersensitivity/allergic reactions." There were no issues related to the efficacy of sugammadex.

Schering-Plough acquired sugammadex in November 2007 through its acquisition of Organon BioSciences, which developed the product.

Schering-Plough is an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The company applies its research-and-development platform to human prescription and consumer products as well as to animal health products. Schering-Plough's vision is to Earn Trust, Every Day with the doctors, patients, customers and other stakeholders served by its colleagues around the world. The company is based in Kenilworth, N.J.,
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. The First Annual Cervical Cancer/HPV Conference Tackles Controversial Vaccine Issues and Encourages Advocacy
2. European Unions CHMP Issues Positive Opinion on PEGINTRON(TM) Combination Therapy for Retreating Hepatitis C Patients Who Failed Previous Therapy
3. European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg)
4. Bayer Issues Additional Guidance to Physicians on Trasylol(R)
5. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on CEL-SCI Corporation
6. QIAGEN and Center for Molecular Medicine Create Research Collaboration for Molecular Diagnostic Markers for Breast Cancer, Other Womens Health Issues
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Bioniche Life Sciences Inc.
8. Lupus Under the Spotlight: U.S. Congress Shows Support for Womens Health Issues
9. European Unions CHMP Issues Positive Opinion on Sugammadex
10. Newly Published Study Shows OPKOs siRNA Bevasiranib Is Taken Up by Target Tissues in the Eye
11. Ending Cervical Cancer Featured at Summit; QIAGEN CEO Issues a Call to Global Women Leaders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... , July 23, 2014  The management team ... ) will hold a conference call on July ... second quarter ended June 30, 2014.  The call ... 2014Time: , 8:30 am EDTDial-in numbers: , Toll ... (412) 317-0790Webcast (live & archive): , www.columbialabs.com ...
(Date:7/23/2014)... -- Global healthcare company GSK reports Q2 ... increased price competition and supply disruptions to its Consumer ... points out that the company is very much in transition, ... confident about long-term prospects as well as the investments ... Simon Dingemans adds that the company is ...
(Date:7/23/2014)... , July 23, 2014 Research ... the "Prepackaged Medical Kits and Trays - ... offering. http://photos.prnewswire.com/prnh/20130307/600769 ... for Prepackaged Medical Kits and Trays in US$ ... Trays, Ophthalmic Custom Trays, Custom Basin Kits, Custom ...
Breaking Medicine Technology:Columbia Laboratories to Discuss Second Quarter 2014 Financial Results on July 31st Conference Call 2Prepackaged Medical Kits and Trays - Global Strategic Business Report: Updated 2014 Report 2
... Club (FC) Barcelona, FC Barcelona Foundation, and ... three-year partnership today to energize the global fight to ... life-saving vaccines.  Bill Gates, co-chair of the Bill & ... Rosell and Manager Josep Guardiola, announced the partnership at ...
... this week at the American Association for Clinical Chemistry (AACC) ... and that testing individuals at risk may be beneficial. ... Health and Nutrition Survey, reported in the Archives of ... D levels over 30 nanogram/millilitre (ng/mL), a level that many ...
Cached Medicine Technology:Futbol Club Barcelona and the Bill & Melinda Gates Foundation Team Up to End Polio and Give Every Child an Equal Shot at Life 2Futbol Club Barcelona and the Bill & Melinda Gates Foundation Team Up to End Polio and Give Every Child an Equal Shot at Life 3Data Presented at American Association for Clinical Chemistry Meeting Show Many Americans May Have Low Vitamin D Levels 2Data Presented at American Association for Clinical Chemistry Meeting Show Many Americans May Have Low Vitamin D Levels 3
(Date:7/23/2014)... 23, 2014 Rich Dad® Education, a leader ... their charity yard sale to support Habit for Humanity of ... of the proceeds will be donated to Habitat for Humanity. ... being donated to the Habitat for Humanity ReStore thrift store ... , One of the highlights of the yard sale ...
(Date:7/23/2014)... 2014 Global Cardio Care, Inc., a ... Counterpulsation (EECP), is celebrating the 100th birthday of ... the health center. , Weber has been plagued ... ongoing EECP therapy since 1999, he no longer suffers ... of Global Cardio Care, introduced the Sara Soulati ...
(Date:7/23/2014)... (PRWEB) July 23, 2014 Bodybuilding.com, the ... online retailer of nutritional supplements, has officially opened the ... BPI SPORTS , the fastest growing sports nutrition company, ... , Brand of the Year, Best Tasting Protein of ... Protein Powder of the year - Whey-HD™, Pre-workout Supplement ...
(Date:7/23/2014)... treating the pernicious disorders of obesity and dementia reside ... University,s Center for Behavioral Neuroscience. In the paper, researchers ... at areas of the brain responsible for memory and ... play a role in reducing certain dementias., "In the ... often fall short. This is a new way for ...
(Date:7/23/2014)... Four hospitals affiliated with the Allegheny Health ... of the country’s best hospitals by U.S. News ... slated for publication in August, the U.S. News 2014-2015 ... Hospital, Saint Vincent Hospital and West Penn Hospital as ... , “There is no higher priority at Allegheny ...
Breaking Medicine News(10 mins):Health News:Rich Dad Education Charity Yard Sale Raises Over $650 for Habitat for Humanity of Lee and Hendry Counties 2Health News:Global Cardio Care Celebrates EECP Patient’s 100th Birthday 2Health News:Vote Now; BPI SPORTS is Nominated for Eight 2014 Bodybuilding.com Supplement Awards 2Health News:Vote Now; BPI SPORTS is Nominated for Eight 2014 Bodybuilding.com Supplement Awards 3Health News:Targeting the brain to treat obesity 2Health News:Targeting the brain to treat obesity 3Health News:Four Allegheny Health Network Hospitals Named High Performers by U.S. News 2Health News:Four Allegheny Health Network Hospitals Named High Performers by U.S. News 3
... Chem Rx (OTC,Bulletin Board: CHRX, CHRXU, CHRXW), a ... company ticker symbol has,changed to CHRX from PMQC. The ... trading community today., About Chem Rx Corporation, ... is a leading,provider of institutional pharmacy services in the ...
... SAN JOSE, Calif., April 18 VNUS(R) Medical,Technologies, Inc. ... has,received a Notice of Allowability by the U.S. Patent ... continuation of one of the three patents in,the VNUS ... The newly allowed VNUS patent application was filed as ...
... 18 AtriCure, Inc.,(Nasdaq: ATRC ), a medical device ... its financial results for the first quarter,ended March 31, 2008 ... conference call at 10:00 a.m. ET on Tuesday, May,6, 2008 ... of the,conference call will be available online from the investor ...
... connection between vitamin D level and the risk ... a long time, but its clinical relevance had ... from the working group headed by Dr. Jenny ... Krebsforschungszentrum, DKFZ), collaborating with researchers of the University ...
... LAKE CITY, April 18 Avalon Health Care, Inc. ... Lake City, Utah has,become the first skilled nursing facility ... Recognition (QRCR) from the American Association,for Respiratory Care (AARC)., ... by acute care,hospitals. This achievement reflects Avalon,s overall goal ...
... Changes in dopamine receptor density affects memory and psychomotor ... -- Long-term exposure to solvents in products such as ... the brain,s wiring, researchers report. , These abnormalities ... encephalopathy (CSE), the Dutch team conclude in the April ...
Cached Medicine News:Health News:Chem Rx Corporation Changes Ticker Symbol to CHRX 2Health News:U.S. Patent Office Allows Significant New VNUS Patent 2Health News:U.S. Patent Office Allows Significant New VNUS Patent 3Health News:AtriCure Announces Web Cast and Conference Call of First Quarter 2008 Financial Results 2Health News:Vitamin D and breast cancer risk 2Health News:Woodland Park Care Center Earns Quality Respiratory Care Recognition 2Health News:Chronic Exposure to Solvents Disturbs Brain's Wiring 2
The Karl Storz Videoscope offers maximum image quality and can be used in combination with standard documentation units. In contrast with conventional flexible endoscopes, images are displayed with ...
Exceptional illumination and realiability from this small source....
The 81483N projector operates off of DC power for maximum portability. The 20 watt halogen bulb with a specially designed reflector provides maximum brightness and portability....
Integrated electronics, single-chip CCD camera with PAL and NTSC output. PAL output at 625 lines, NTSC output at 525 lines. 23mm focal length. Output via Y/C mini-DIN-4 port. 135mm length x 44mm ...
Medicine Products: